The abstract is read at the publisher; the summary is JClub's.
DreaMS, a transformer pre-trained on millions of unannotated MS/MS spectra from the GeMS dataset, learns rich molecular-structure representations that enable state-of-the-art fine-tuned predictions.
- Why it matters: Untargeted metabolomics interpretation is limited by small spectral libraries and hard-coded expertise, leaving MS/MS predictions difficult without extensive annotations.
- What they did: The model is self-supervised on millions of spectra by predicting masked spectral peaks and chromatographic retention orders, then fine-tuned for downstream tasks.
- The result: Fine-tuning achieves state-of-the-art performance across multiple tasks, and the released DreaMS Atlas contains 201 million MS/MS spectra annotated using DreaMS.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.